2Fabbri LM, Hurd SS;GOLD scientific committce global straicgy for the diagnosis, manageneut, and preventi on of COPD:L2003 update[J].Eur Respir J, 2003,22 : 1-2.
二级参考文献24
1Pin I, Gibson PG, Kolendowicz R, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax,1992, 47: 25-29.
2Pizzichini MM,Pizzichini E, Clelland L, et al. Sputum in severe exacerbations of sathma: kinetics of inflammatory indices after prednisone treatment. Am J Respir Crit Care Med, 1997, 155:1501-1508.
3Ronchi MC, Piragino C, Rosi E, et al. Role of sputum differential cell count in detecting airway inflammation in patients with chronic bronchial asthma or COPD. Thorax, 1996,51:1000-1004.
4Jatakanon A, Uasuf C, Maziak W, et al. Neutrophilic inflammation in seere persistent asthma. Am J Respir Crit Care Med.1999,160(5 Pt 1):1532-1539.
5Takanashi S, Hasegawa Y, Kanehira Y, et al. Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers. Eur Respir J, 1999,14:309-314.
6Saetta M, Di Stefano A, Maestrelli P, et al. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med, 1994, 150 (6 Pt 1):1646-1652.
7Bhowmik A, Seemungal TA, Sapsford RJ, et al. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax, 2000, 55:114-120.
8Crooks SW, Bayley DL, Hill SL, et al. Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4. Eur Respir J, 2000, 15:274-280.
9Parameswaran K, Pizzichini E, Pizzichini MM, et al. Clinical judgment of airway inflammation versus sputum cell counts in patients with asthma. Eur Respir J, 2000, 15:486-490.
10Jang AS, Choi IS. Eosinophil activation markers in induced sputum in asthmatics. Korean J Intern Med, 2000, 15: 1-7.
